Treatment of gram-positive nosocomial pneumonia. Prospective randomized comparison of quinupristin/dalfopristin versus vancomycin. Nosocomial Pneumonia Group. (Q53338170)

From Wikidata

Jump to navigation Jump to search

scientific article published in March 2000

Language	Label	Description	Also known as
English	Treatment of gram-positive nosocomial pneumonia. Prospective randomized comparison of quinupristin/dalfopristin versus vancomycin. Nosocomial Pneumonia Group.	scientific article published in March 2000

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/10712318

Treatment of gram-positive nosocomial pneumonia. Prospective randomized comparison of quinupristin/dalfopristin versus vancomycin. Nosocomial Pneumonia Group. (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/10712318

0 references

0 references

author name string

Fagon J

1

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/10712318

Patrick H

2

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/10712318

Haas DW

3

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/10712318

Torres A

4

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/10712318

Gibert C

5

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/10712318

Cheadle WG

6

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/10712318

Falcone RE

7

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/10712318

Anholm JD

8

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/10712318

Paganin F

9

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/10712318

Fabian TC

10

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/10712318

Lilienthal F

11

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/10712318

language of work or name

0 references

publication date

1 March 2000

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/10712318

American Journal of Respiratory and Critical Care Medicine

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/10712318

161

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/10712318

3 Pt 1

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/10712318

753-762

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/10712318

Epidemiology of nosocomial pneumonia. New perspectives on an old disease.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.3.9904115

21 January 2018

Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.3.9904115

21 January 2018

The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.3.9904115

21 January 2018

Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.3.9904115

21 January 2018

The evolving epidemiology of methicillin-resistant Staphylococcus aureus at a university hospital

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.3.9904115

21 January 2018

Impact of methicillin-resistant Staphylococcus aureus on the incidence of nosocomial staphylococcal infections

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.3.9904115

21 January 2018

Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.3.9904115

21 January 2018

Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.3.9904115

21 January 2018

Recommendations for preventing the spread of vancomycin resistance

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.3.9904115

21 January 2018

Nosocomial pneumonia. A multivariate analysis of risk and prognosis.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.3.9904115

21 January 2018

Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.3.9904115

21 January 2018

Ceftazidime versus tobramycin-ticarcillin in the treatment of pneumonia and bacteremia

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.3.9904115

21 January 2018

Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.3.9904115

21 January 2018

Prospective randomized controlled study of ciprofloxacin versus imipenem-cilastatin in severe clinical infections

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.3.9904115

21 January 2018

APACHE II: a severity of disease classification system

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.3.9904115

21 January 2018

The effect of late-onset ventilator-associated pneumonia in determining patient mortality

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.3.9904115

21 January 2018

Treatment of ventilator-associated pneumonia with piperacillin-tazobactam/amikacin versus ceftazidime/amikacin: a multicenter, randomized controlled trial. VAP Study Group

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.3.9904115

21 January 2018

Identifiers

10.1164/AJRCCM.161.3.9904115

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/10712318

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/10712318

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53338170&oldid=1613286649"